Method of cardiac imaging with the use of hyperpolarized 13 c-pyruvate

Research output: Patent


The invention relates to a method of cardiac imaging using hyperpolarised 13C-pyruvate as MR imaging agent, which allows determination of the viability of cells in the myocardium.


  • Mathilde H Lerche (Inventor)
  • René In 'T Zandt (Inventor)
  • K. Golman (Inventor)
  • M Thaning (Inventor)
  • Jan-Henrik Ardenkjaer-Larsen (Inventor)
  • J Stefan Petersson (Inventor)
External organisations
  • GE Healthcare, Malmö
Original languageEnglish
Patent numberWO2006054903 A3
Priority date2004/11/19
StatePublished - 2007 Mar 15
Publication categoryResearch
Externally publishedYes

Bibliographic note

WO Patent App. PCT/NO2005/000,434